Search results
Results from the WOW.Com Content Network
GSK plc (an acronym from its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company with headquarters in London. [3] [4] It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, [n 1] which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm.
October 9, 2024 at 11:56 PM. GSK has reached agreements with law firms representing around 80,000 claimants [Getty Images] UK pharmaceutical giant GSK says it will pay as much as $2.2bn (£1.68bn ...
In the past 52 weeks, GlaxoSmithKline PLC share prices are bracketed by a low of $33.26 and a hi. GlaxoSmithKline PLC (NYSE: GSK) traded at a new 52-week high today of $42.68. This new high was ...
Rotarix (human rotavirus vaccine, live attenuated) Shingrix (for Zoster Vaccine Recombinant, Adjuvanted) Synflorix (pneumococcal polysaccharide conjugate vaccine (adsorbed)) Twinrix (for combined hepatitis A (inactivated virus) and hepatitis B vaccine (genetically derived surface antigen)) Typherix (typhoid vaccine (purified polysaccharide ...
The analysis of the full trial data, including the key secondary endpoint of overall survival, is ongoing, said GSK. ($1 = 0.7881 pounds) (Reporting by Aby Jose Koilparambil in Bengaluru; Editing ...
Even though the FTSE All-Share Index is more comprehensive, the FTSE 100 is by far the most widely used UK stock market indicator. Other related indices are the FTSE 250 Index (which includes the next largest 250 companies after the FTSE 100), the FTSE 350 Index (which is the aggregation of the FTSE 100 and 250), FTSE SmallCap Index and the ...
GSK plc (76.5%) Pfizer (13.5%) Shionogi (10%) Number of employees. c. 1,100 (2023) Website. viivhealthcare.com. ViiV Healthcare (/ ˈviːv / VEEV) is a British multinational pharmaceutical company specializing in the research and development of medicines to treat and prevent HIV/AIDS. Its global headquarters is located in London.
GSK also said that patent protection for its best-selling antiviral ingredient dolutegravir, which is used in HIV drugs and had a combined 1.3 billion pounds in second-quarter sales, would expire ...